Regulus Therapeutics Inc. (RGLS) Social Stream



Regulus Therapeutics Inc. (RGLS): $1.49

0.03 (+2.05%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add RGLS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#271 of 328

in industry

Featured Post From StockTwits About RGLS

$RGLS So we have $0.55 a share in cash. Means the street is valuing entire company for $7.7m (not including convert. debt). I believe they have 250 micro RNA related patents/IP and a potential blockbuster product in RGLS 4326..

Definite disconnect with stock and real value. Not gonna touch any shares until we get over $6.00 in 2022. We should bounce back on any positive and once this UGLY UGLY UGLY tax loss selling season is over by end of October...
Elvira007, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!